Skip to main content
. 2021 Apr 8;8(1):e001526. doi: 10.1136/openhrt-2020-001526

Table 3.

Composite outcome (in-hospital death or in-hospital MACE)

Variable No events*
(n=615)
Composite outcome*
(n=224)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
P value
History of CV disease 136 (22%) 141 (63%) 6.0 (4.3 to 8.4) 2.4 (1.6 to 3.5) <0.001
Age (per 10 years) 60 (50–75) 82 (74–88) 2.3 (2.0 to 2.7) 2.2 (1.9 to 2.6) <0.001
Male gender 321 (52%) 132 (59%) 1.3 (.97 to 1.8) 1.6 (1.1 to 2.3) 0.02
Lung opacity/infiltration 100 (16%) 51 (23%) 1.5 (1.0 to 2.2) 1.9 (1.2 to 3) 0.01
Hypertension 249 (40%) 143 (64%) 2.6 (1.9 to 3.6) 0.87 (0.58 to 1.3) 0.50
Obesity† 153/544 (28%) 53/215 (25%) 0.84 (0.58 to 1.2)
Dyslipidaemia 131 (21%) 74 (33%) 1.8 (1.3 to 2.6) 0.89 (0.58 to 1.3) 0.57
Diabetes 105 (17%) 64 (29%) 1.9 (1.4 to 2.8) 1.5 (0.95 to 2.3) 0.08
Smoking 26 (4%) 11 (5%) 1.2 (0.55 to 2.3) 1.5 (0.6 to 3.4) 0.37
COPD 22 (4%) 27 (12%) 3.7 (2.1 to 6.7) 2.1 (1.1 to 4.2) 0.03
OSA 46 (7%) 23 (10%) 1.4 (0.82 to 2.4) 1.4 (0.7 to 2.6) 0.28

*Data are n (%) or median (Q1–Q3).

†Missing BMI: n=80.

BMI, body mass index; COPD, chronic obstructive pulmonary disease; CV, cardiovascular; MACE, major adverse cardiovascular event; OSA, obstructive sleep apnea.